文献速递皮肤肿瘤毛发、甲与色素性疾病

黑皮质素-1受体慢性激活的获益与风险概述

An overview of benefits and risks of chronic melanocortin-1 receptor activation.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2024-07-31

本文综述MC1R在皮肤色素、黑色素合成、氧化还原稳态和炎症中的作用,梳理Addison病、妊娠黄褐斑及紫外线暴露等慢性激活情境,并汇总已获批黑皮质素激动剂在红细胞生成性原卟啉症、性欲障碍及肥胖中的获益与风险。

要点

  • MC1R慢性激活可源于疾病、生理状态或紫外线暴露。
  • 已获批黑皮质素激动剂可靶向激活MC1R信号。
  • MC1R激活诱导色素和DNA修复,但不预防黑色素瘤。

核心结论

  • MC1R慢性激活既有保护性作用也有风险,高风险人群仍需定期皮肤检查。

研究设计与样本

  • 综述,围绕MC1R的生理作用、慢性激活情境及黑皮质素激动剂的获益与风险进行概述。

主要发现

  • MC1R功能缺失变异降低腺苷酸环化酶激活和细胞内cAMP水平。
  • Addison病、妊娠黄褐斑及紫外线暴露可导致MC1R慢性激活。
  • 已获批黑皮质素激动剂用于红细胞生成性原卟啉症、性欲障碍、单基因肥胖和综合征性肥胖。
  • α-MSH小肽类似物及人MC1R选择性激动剂具光保护作用,正在研究作为化学预防策略。
  • MC1R激活通过诱导紫外线保护性色素、增加DNA修复和控制异常细胞生长可能降低黑色素瘤风险,但不预防黑色素瘤。

临床怎么用

  • 对高风险个体定期皮肤检查仍至关重要,不应因MC1R激活的保护作用而放松监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The melanocortin-1 receptor (MC1R) is a G protein-coupled receptor that plays a pivotal role in human skin pigmentation, melanin synthesis, redox homeostasis and inflammation. Loss-of-function MC1R variants suppress G protein-coupled receptor coupling or cell surface expression leading to a decrease in adenyl cyclase activation and intracellular levels of cyclic adenosine monophosphate. Chronic activation of MC1R can occur in certain medical conditions such as Addison's disease and physiologic states such as pregnancy melasma. MC1R activation is more commonly caused by environmental exposure to ultraviolet (UV) radiation. Approved pharmacologic melanocortin agonists that activate MC1R signalling in a targeted manner or as a bystander effect have recently become available for erythropoietic protoporphyria, sexual desire disorders, monogenic obesity and syndromic obesity. Further, small peptide analogues of α-melanocortin-stimulating hormone, human MC1R selective agonists, are photoprotective, decreasing the adverse impact of UV radiation (a primary risk factor for skin cancer) and are being investigated as potential chemoprevention strategies. MC1R activation through induction of UV-protective skin pigmentation increased DNA repair, and control of aberrant cell growth may reduce the risk of melanoma but importantly does not prevent melanoma particularly in individuals with risk factors and regular skin examination remains critical in high-risk individuals.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Böhm M, Robert C, Malhotra S, et al. An overview of benefits and risks of chronic melanocortin-1 receptor activation. J Eur Acad Dermatol Venereol. 2024. PMID: 39082868. doi:10.1111/jdv.20269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。